← Back to Search

Safety Shot for Alcohol Consumption Effects

N/A
Recruiting
Research Sponsored by The Center for Applied Health Sciences, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Body weight of at least 110 pounds
Age between the ages of 21 and 55 (inclusive)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 30 minutes, 45 minutes, 60 minutes, 120 minutes, 180 minutes and 240 minutes.
Awards & highlights

Study Summary

This trial tests how dietary supplements affect blood & breath levels after drinking alcohol in 36 healthy adults.

Who is the study for?
This trial is for healthy men and women aged 21-55, with normal blood pressure, heart rate, BMI of 18.5-34.9, and weight over 110 pounds. Participants must not have diabetes, certain cancers within the last five years or be pregnant/nursing; they should also avoid alcohol/caffeine before trials and agree to transport home after.Check my eligibility
What is being tested?
The study tests a dietary supplement's effect on alcohol levels in the body compared to a placebo. It involves 36 participants who will randomly receive either the supplement or placebo in a controlled environment to see if it alters blood and breath alcohol concentrations.See study design
What are the potential side effects?
Potential side effects are not specified but may include reactions related to ingredients in the dietary supplement or due to interaction with alcohol consumption.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I weigh at least 110 pounds.
Select...
I am between 21 and 55 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 30 minutes, 45 minutes, 60 minutes, 120 minutes, 180 minutes and 240 minutes.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 30 minutes, 45 minutes, 60 minutes, 120 minutes, 180 minutes and 240 minutes. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Concentration
Energy
Fatigue
+4 more
Secondary outcome measures
Blood acetaldehyde level
Blood alcohol dehydrogenase level
Blood alcohol level
+3 more
Other outcome measures
Diastolic blood pressure
Heart rate
Systolic blood pressure

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Safety ShotExperimental Treatment1 Intervention
12 oz of Safety Shot containing a blend of vitamins, minerals and botanical extracts.
Group II: PlaceboPlacebo Group1 Intervention
12 oz of flavor-matched water.

Find a Location

Who is running the clinical trial?

The Center for Applied Health Sciences, LLCLead Sponsor
11 Previous Clinical Trials
577 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this clinical experiment open to me?

"This research study is in search of 36 participants who consume alcohol and are between 21 to 55 years old. To be considered, those criteria must both be met."

Answered by AI

Is the elderly population being considered for enrollment in this experimental protocol?

"This research endeavour is seeking out individuals aged between 21 and 55 years old."

Answered by AI

Are there any openings for participation in this experiment?

"The information posted on clinicaltrials.gov demonstrates that this medical trial is not currently seeking patients, although it was initially published in November 1st 2023 and its data was most recently refreshed on October 24th 2023. Nevertheless, there are other 270 studies enrolling volunteers right now."

Answered by AI

What is the ultimate goal of this experiment?

"The primary intent of this clinical trial is to assess the efficacy of a treatment on blood alcohol level over an extended period, with data collection from baseline up to 240 minutes. Secondary objectives include gauging patient symptoms, such as nausea, fatigue and energy levels using 10 cm visual analogue scales (VAS)."

Answered by AI
~24 spots leftby Apr 2025